![](/img/cover-not-exists.png)
Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment
Betrian, S, Ysebaert, L, Heider, K H, Delord, J P, Fournié, J J, Quillet-Mary, AVolume:
6
Language:
english
Journal:
Blood Cancer Journal
DOI:
10.1038/bcj.2016.106
Date:
November, 2016
File:
PDF, 588 KB
english, 2016